Maltin Wealth Management »

Trevi Therapeutics shares owned by Maltin Wealth Management

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Maltin Wealth Management from 13F filings

Historical chart of Maltin Wealth Management investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Maltin Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Maltin Wealth Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $126k 11k 11.93

More positions owned by Maltin Wealth Management

Invesco Exch Traded Fd Tr Ii Rafi Dvlpd Mrkts (PXF)
Uscf Etf Tr Summerhaven K1 (SDCI)
First Tr Exchng Traded Fd Vi Ft Vest Us Eqt (RSSE)
Gmo Etf Trust Gmo Intl Value (GMOI)
Vanguard Intl Equity Index F Ftse Smcap Etf (VSS)
Ishares Gold Tr Ishares New (IAU)
Ishares Tr Core High Dv Etf (HDV)
Innovator Etfs Trust Us Small Cap Pwr (KDEC)
Invesco Exch Traded Fd Tr Ii Taxable Mun Bd (BAB)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard World Industrial Etf (VIS)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Innovator Etfs Trust Intl Dev Pwr Buf (INOV)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Emrg (PIE)

View all positions for Maltin Wealth Management

Top funds holding Trevi Therapeutics

NEA Management Company
BlackRock
Frazier Life Sciences Management
FMR
Vanguard Group
Vivo Capital
Vanguard Capital Management
Marshall Wace
Rubric Capital Management
Wellington Management Company
MPM Oncology Impact Management
Viking Global Investors
Alliancebernstein
Geode Capital Management
Eventide Asset Management

View all funds holding Trevi Therapeutics